My first patient was myself
Why Continuous GLP-1 Therapy May Be a Better Option Rather than stopping GLP-1 treatment altogether, many patients benefit from switching to an affordable, compounded alternative that allows them to continue therapy long-term
Peptides (2022) 148:170683
[10] Those affected by vitiligo who are stigmatized for their condition may experience depression and similar mood disorders
Garetosmab, activin A inhibitor antibody for muscle-preservation combination regimens in obesity Recent Highlights: In June 2026, the company announced it would present new clinical data from the Phase 2 COURAGE trial that examines the effects of trevogrumab (anti-GDF8) on lean mass in people with obesity treated with semaglutide
Some women with polycystic ovary syndrome (PCOS) have reported improved menstrual regularity whilst taking GLP-1 medications, though this is likely related to weight loss and improved insulin sensitivity rather than a direct pharmacological effect on ovarian function